TipRanks
Sanofi (SNYNF)
OTHER OTC:SNYNF
US Market
SNYNF
Sanofi
RESEARCH TOOLSreports

Sanofi (SNYNF) Stock Forecast & Price Target

392 Followers
See the Price Targets and Ratings of:

SNYNF Analyst Ratings

Moderate Buy
13Ratings
Moderate Buy
6 Buy
7 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Sanofi
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SNYNF Stock 12 Month Forecast

Average Price Target

$105.27
▲(14.42% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Sanofi in the last 3 months. The average price target is $105.27 with a high forecast of $120.31 and a low forecast of $90.62. The average price target represents a 14.42% change from the last price of $92.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"79":"$79","100":"$100","121":"$121","89.5":"$89.5","110.5":"$110.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":120.31309484999998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$120.31</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":105.26765044090908,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$105.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90.6228,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.62</span>\n  </div></div>","useHTML":true}}],"tickPositions":[79,89.5,100,110.5,121],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.764,83.8062380653846,86.84847613076923,89.89071419615384,92.93295226153845,95.97519032692307,99.01742839230768,102.05966645769229,105.10190452307691,108.14414258846153,111.18638065384614,114.22861871923075,117.27085678461538,{"y":120.31309484999998,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.764,82.64889618776223,84.53379237552447,86.41868856328671,88.30358475104894,90.18848093881118,92.07337712657342,93.95827331433566,95.8431695020979,97.72806568986013,99.61296187762237,101.4978580653846,103.38275425314684,{"y":105.26765044090908,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.764,81.52236923076923,82.28073846153846,83.0391076923077,83.79747692307691,84.55584615384615,85.31421538461538,86.07258461538461,86.83095384615385,87.58932307692308,88.3476923076923,89.10606153846153,89.86443076923076,{"y":90.6228,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":93.662,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.365,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.392,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.049,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.854,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.57,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.244,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.739,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.95,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.29,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.866,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.102,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.764,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$120.31Average Price Target$105.27Lowest Price Target$90.62
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on SNYNF
Trung Huynh
RBC Capital
RBC Capital
$90.62
Hold
-1.50%
Downside
Reiterated
10/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Sagimet Biosciences, Inc. Class A (NASDAQ: SGMT) and Eli Lilly & Co (NYSE: LLY)
J.P. Morgan Analyst forecast on SNYNF
Richard Vosser
J.P. Morgan
J.P. Morgan
$107.61
Hold
16.97%
Upside
Reiterated
10/01/26
Analysts Conflicted on These Healthcare Names: Spyre Therapeutics (NASDAQ: SYRE), Sanofi (Other OTC: SNYNF) and Nektar Therapeutics (NASDAQ: NKTR)
Jefferies Analyst forecast on SNYNF
Michael Leuchten
Jefferies
Jefferies
$113.28
Buy
23.13%
Upside
Reiterated
10/01/26
Sanofi (SNYNF) Gets a Buy from Jefferies
Deutsche Bank Analyst forecast on SNYNF
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
$107.61
Buy
16.97%
Upside
Reiterated
09/29/26
Sanofi (SNYNF) Receives a Buy from Deutsche Bank
UBS Analyst forecast on SNYNF
Matthew Weston
UBS
UBS
―
Hold
―
Reiterated
09/17/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Amgen (NASDAQ: AMGN) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)
HSBC Analyst forecast on SNYNF
Rajesh Kumar
HSBC
HSBC
$107.61→$113.28
Buy
23.13%
Upside
Reiterated
09/10/26
Sanofi price target raised to EUR 100 from EUR 95 at HSBCSanofi price target raised to EUR 100 from EUR 95 at HSBC
Barclays Analyst forecast on SNYNF
James Gordon CFA
Barclays
Barclays
$89.49→$94.02
Hold
2.20%
Upside
Reiterated
09/08/26
Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Merck & Company (NYSE: MRK)
Bank of America Securities Analyst forecast on SNYNF
Sachin Jain
Bank of America Securities
Bank of America Securities
$104.22
Hold
13.28%
Upside
Reiterated
09/04/26
Bank of America Securities Remains a Hold on Sanofi (SNYNF)
Berenberg Bank Analyst forecast on SNYNF
Luisa Hector
Berenberg Bank
Berenberg Bank
$118.94
Buy
29.29%
Upside
Reiterated
08/24/26
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (NASDAQ: RANI) and Sanofi (Other OTC: SNYNF)
Morgan Stanley Analyst forecast on SNYNF
Sarita Kapila
Morgan Stanley
Morgan Stanley
$97.42→$92.89
Hold
0.97%
Upside
Reiterated
08/11/26
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan StanleySanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
Bernstein Analyst forecast on SNYNF
Justin Smith
Bernstein
Bernstein
$121.21→$120.31
Buy
30.78%
Upside
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
DZ BANK AG Analyst forecast on SNYNF
Elmar Kraus
DZ BANK AG
DZ BANK AG
―
Buy
―
Reiterated
07/31/26
Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Sanofi (SNYNF)
Goldman Sachs Analyst forecast on SNYNF
James Quigley
Goldman Sachs
Goldman Sachs
$100.82→$95.15
Hold
3.43%
Upside
Reiterated
07/06/26
Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC), Dogwood Therapeutics (NASDAQ: DWTX) and Sanofi (Other OTC: SNYNF)
Kepler Capital Analyst forecast on SNYNF
Nicolas Pauillac
Kepler Capital
Kepler Capital
$96.29
Hold
4.66%
Upside
Reiterated
04/23/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)
Citi Analyst forecast on SNYNF
Graham Parry
Citi
Citi
$96.29→$90.62
Hold
-1.50%
Downside
Reiterated
02/20/26
Sanofi price target lowered to EUR 80 from EUR 85 at CitiSanofi price target lowered to EUR 80 from EUR 85 at Citi
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on SNYNF
Trung Huynh
RBC Capital
RBC Capital
$90.62
Hold
-1.50%
Downside
Reiterated
10/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Sagimet Biosciences, Inc. Class A (NASDAQ: SGMT) and Eli Lilly & Co (NYSE: LLY)
J.P. Morgan Analyst forecast on SNYNF
Richard Vosser
J.P. Morgan
J.P. Morgan
$107.61
Hold
16.97%
Upside
Reiterated
10/01/26
Analysts Conflicted on These Healthcare Names: Spyre Therapeutics (NASDAQ: SYRE), Sanofi (Other OTC: SNYNF) and Nektar Therapeutics (NASDAQ: NKTR)
Jefferies Analyst forecast on SNYNF
Michael Leuchten
Jefferies
Jefferies
$113.28
Buy
23.13%
Upside
Reiterated
10/01/26
Sanofi (SNYNF) Gets a Buy from Jefferies
Deutsche Bank Analyst forecast on SNYNF
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
$107.61
Buy
16.97%
Upside
Reiterated
09/29/26
Sanofi (SNYNF) Receives a Buy from Deutsche Bank
UBS Analyst forecast on SNYNF
Matthew Weston
UBS
UBS
―
Hold
―
Reiterated
09/17/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Amgen (NASDAQ: AMGN) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)
HSBC Analyst forecast on SNYNF
Rajesh Kumar
HSBC
HSBC
$107.61→$113.28
Buy
23.13%
Upside
Reiterated
09/10/26
Sanofi price target raised to EUR 100 from EUR 95 at HSBCSanofi price target raised to EUR 100 from EUR 95 at HSBC
Barclays Analyst forecast on SNYNF
James Gordon CFA
Barclays
Barclays
$89.49→$94.02
Hold
2.20%
Upside
Reiterated
09/08/26
Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Merck & Company (NYSE: MRK)
Bank of America Securities Analyst forecast on SNYNF
Sachin Jain
Bank of America Securities
Bank of America Securities
$104.22
Hold
13.28%
Upside
Reiterated
09/04/26
Bank of America Securities Remains a Hold on Sanofi (SNYNF)
Berenberg Bank Analyst forecast on SNYNF
Luisa Hector
Berenberg Bank
Berenberg Bank
$118.94
Buy
29.29%
Upside
Reiterated
08/24/26
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (NASDAQ: RANI) and Sanofi (Other OTC: SNYNF)
Morgan Stanley Analyst forecast on SNYNF
Sarita Kapila
Morgan Stanley
Morgan Stanley
$97.42→$92.89
Hold
0.97%
Upside
Reiterated
08/11/26
Sanofi price target lowered to EUR 82 from EUR 86 at Morgan StanleySanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley
Bernstein Analyst forecast on SNYNF
Justin Smith
Bernstein
Bernstein
$121.21→$120.31
Buy
30.78%
Upside
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
DZ BANK AG Analyst forecast on SNYNF
Elmar Kraus
DZ BANK AG
DZ BANK AG
―
Buy
―
Reiterated
07/31/26
Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Sanofi (SNYNF)
Goldman Sachs Analyst forecast on SNYNF
James Quigley
Goldman Sachs
Goldman Sachs
$100.82→$95.15
Hold
3.43%
Upside
Reiterated
07/06/26
Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC), Dogwood Therapeutics (NASDAQ: DWTX) and Sanofi (Other OTC: SNYNF)
Kepler Capital Analyst forecast on SNYNF
Nicolas Pauillac
Kepler Capital
Kepler Capital
$96.29
Hold
4.66%
Upside
Reiterated
04/23/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)
Citi Analyst forecast on SNYNF
Graham Parry
Citi
Citi
$96.29→$90.62
Hold
-1.50%
Downside
Reiterated
02/20/26
Sanofi price target lowered to EUR 80 from EUR 85 at CitiSanofi price target lowered to EUR 80 from EUR 85 at Citi
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OMCLOmnicell
KNSAKiniksa Pharmaceuticals
ACHVAchieve Life Sciences
AHCOAdaptHealth
ZVRAZevra Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sanofi

3 Months
David RisingerLeerink Partners
Success Rate
19/35 ratings generated profit
54%
Average Return
-0.30%
Copying David Risinger's trades and holding each position for 3 Months would result in 54.29% of your transactions generating a profit, with an average return of -0.30% per trade.
1 Year
David RisingerLeerink Partners
Success Rate
20/35 ratings generated profit
57%
Average Return
+2.24%
Copying David Risinger's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +2.24% per trade.
2 Years
Emmanuel PapadakisDeutsche Bank
Success Rate
22/55 ratings generated profit
40%
Average Return
-2.71%
Copying Emmanuel Papadakis's trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -2.71% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SNYNF Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
10
10
14
15
11
Hold
9
12
13
17
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
22
27
32
20
In the current month, SNYNF has received 11 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. SNYNF average Analyst price target in the past 3 months is 105.27.
Each month's total comprises the sum of three months' worth of ratings.

SNYNF Financial Forecast

SNYNF Earnings Forecast

Next quarter’s earnings estimate for SNYNF is $3.15 with a range of $2.76 to $3.57. The previous quarter’s EPS was $2.37. SNYNF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SNYNF has Performed in-line its overall industry.
Next quarter’s earnings estimate for SNYNF is $3.15 with a range of $2.76 to $3.57. The previous quarter’s EPS was $2.37. SNYNF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SNYNF has Performed in-line its overall industry.

SNYNF Sales Forecast

Next quarter’s sales forecast for SNYNF is $15.45B with a range of $14.72B to $15.95B. The previous quarter’s sales results were $25.04B. SNYNF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SNYNF has Performed in-line its overall industry.
Next quarter’s sales forecast for SNYNF is $15.45B with a range of $14.72B to $15.95B. The previous quarter’s sales results were $25.04B. SNYNF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SNYNF has Performed in-line its overall industry.

SNYNF Stock Forecast FAQ

What is SNYNF’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is 105.27.
    What is SNYNF’s upside potential, based on the analysts’ average price target?
    Sanofi has 14.42% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SNYNF a Buy, Sell or Hold?
          Sanofi has a consensus rating of Moderate Buy which is based on 6 buy ratings, 7 hold ratings and 0 sell ratings.
            What is Sanofi’s price target?
            The average price target for Sanofi is 105.27. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $120.31 ,the lowest forecast is $90.62. The average price target represents 14.42% Increase from the current price of $92.
              What do analysts say about Sanofi?
              Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of SNYNF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.